Boston, MA, United States of America

Kyung-Jin Jang

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.1

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kyung-Jin Jang in Microfluidic Technology

Introduction

Kyung-Jin Jang is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of microfluidic devices, particularly in the development of kidney-on-chip technologies. With a total of 3 patents to his name, Jang's work is paving the way for advancements in drug testing and personalized medicine.

Latest Patents

One of Jang's latest patents is focused on the microfluidic proximal tubule kidney-on-chip. This invention relates to microfluidic fluidic devices, methods, and systems designed as kidney-on-chips, including the human Proximal Tubule-Kidney-Chip, Glomerulus (Kidney)-Chip, and Collecting Duct (Kidney)-Chip. The devices, methods, and systems described in this patent are utilized for drug testing, including drug transport and renal clearance. Furthermore, they are instrumental in determining drug-drug interactions and their effects on renal transporter functions. Importantly, these innovations may be applied in pre-clinical and clinical drug development for treating kidney diseases and advancing personalized medicine.

Career Highlights

Kyung-Jin Jang is currently employed at Emulate, Inc., where he continues to innovate in the field of microfluidics. His work is characterized by a commitment to improving healthcare through technology.

Collaborations

Jang collaborates with notable colleagues, including Hyoungshin Park and Sauveur Jeanty, who contribute to the innovative environment at Emulate, Inc.

Conclusion

Kyung-Jin Jang's contributions to microfluidic technology are significant and impactful. His inventions are not only advancing scientific understanding but also enhancing the potential for personalized medicine in treating kidney diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…